Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter studyFengzhu Guo(Chinese Academy of Medical Sciences & Peking Union Medical College)Cancer MedicineSeptember 2, 202110.1002/cam4.4215Cited by 9SaveCiteExport RISWatch citationsRelated PapersPRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer|Cell Death and Disease|2023|11